Gritstone Bio Inc (GRTS)
0.7465
-0.03
(-3.50%)
USD |
NASDAQ |
Apr 17, 16:00
0.7465
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Cash from Operations (TTM): -121.65M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -121.65M |
September 30, 2023 | -132.51M |
June 30, 2023 | -127.21M |
March 31, 2023 | -122.58M |
December 31, 2022 | -115.95M |
September 30, 2022 | -109.35M |
June 30, 2022 | -98.44M |
March 31, 2022 | -94.78M |
December 31, 2021 | -50.68M |
September 30, 2021 | -52.12M |
June 30, 2021 | -57.42M |
Date | Value |
---|---|
March 31, 2021 | -55.47M |
December 31, 2020 | -89.10M |
September 30, 2020 | -86.34M |
June 30, 2020 | -91.18M |
March 31, 2020 | -88.86M |
December 31, 2019 | -85.01M |
September 30, 2019 | -75.56M |
June 30, 2019 | -48.63M |
March 31, 2019 | -42.23M |
December 31, 2018 | -38.16M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-132.51M
Minimum
Sep 2023
-48.63M
Maximum
Jun 2019
-89.62M
Average
-89.10M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
Precision BioSciences Inc | -84.11M |
Humacyte Inc | -73.30M |
Verastem Inc | -86.46M |
BioVie Inc | -41.11M |
Syros Pharmaceuticals Inc | -109.71M |